AVIR

Atea Pharmaceuticals (AVIR)

About Atea Pharmaceuticals (AVIR)

Atea Pharmaceuticals, Inc. is a clinical stage company, which focuses on discovering, developing, and commercializing antiviral therapeutics. Its product pipelines include Coronaviridae, Flaviviridae, and Paramyxovirdae. The company was founded by Jean-Pierre Sommadossi and David Chu in July 2012 and is headquartered in Boston, MA.

Details

Daily high

$3.26

Daily low

$3.14

Price at open

$3.15

52 Week High

$4.02

52 Week Low

$2.46

Market cap

246.1M

Dividend yield

0.00%

Volume

456,313

Avg. volume

357,504

P/E ratio

-1.77

Atea Pharmaceuticals News